BUILDING COMPANIES THAT IMPROVE LIVES
Jeff is currently chairman and chief executive officer of Paragon Biosciences, LLC. Paragon Biosciences is focused on improving the lives of patients suffering from debilitating diseases by building innovative biotechnology companies that bring important medicines to the market. The company's leadership and management team leverages their entrepreneurial experiences, and their expertise in securing 13 FDA drug approvals, to develop and finance biotechnology companies and accelerate their advancements. Patients come first, as Paragon’s family of companies power medical breakthroughs with the support and collaboration of health care providers and key stakeholders involved in delivering healthcare services. Jeff is the co-founder and non-executive chairman of Castle Creek Pharma and non executive chairman of Harmony Biosciences.
Jeff has served as chairman of a number of biotech and pharma companies, including Paragon Pharmaceuticals, MedCare Technologies, and Marathon Pharmaceuticals. Previously, Jeff served as president and chief executive officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000. In 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc.
Throughout his career, Jeff has received honors for his entrepreneurship and patient-focused dedication to bringing new medicines to market. These achievements include: the 2017 Weizmann Leadership Award, Brain Research Foundation, Frederic A. Gibbs Discovery Award, 2013; Buyouts magazine "Deal of the Year" 2010, Ovation Pharmaceuticals; Illinois Holocaust Museum & Education Center's Humanitarian Award, 2010; Pharmaceutical Executive magazine's "45 under 45," 2008; Epilepsy Foundation of Greater Chicago, Rovner Award, 2007; Scrip Award "Pharma Company of the Year-Small and Medium-sized Enterprises," 2006, 2007, Ovation Pharmaceuticals; and the Ernst & Young "Entrepreneur of the Year" among Emerging Companies (Lake Michigan area), Finalist 2006,